Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
BMC Med Genet ; 21(1): 18, 2020 01 30.
Article in English | MEDLINE | ID: mdl-32000717

ABSTRACT

BACKGROUND: Joubert syndrome is a genetically heterogeneous autosomal recessive ciliopathy characterized by the combination of hypoplasia/aplasia of the cerebellar vermis, thickened and elongated superior cerebellar peduncles and a deep interpeduncular fossa, known as "molar tooth sign" associated with hypotonia, respiratory control disturbances and abnormal eye movements. To date, pathogenic variants in over 35 genes are known to cause autosomal recessive Joubert Syndrome, while one gene is associated with X-linked recessive inheritance. CASE PRESENTATION: We describe here a non-consanguineous Vietnamese family with Joubert syndrome, a fetus and 10-year-old developmentally delayed boy. Ultrasonography showed ventriculomegaly at 26 + 6 weeks of gestation in the fetus. The 10-year-old-boy was diagnosed with cerebral palsy of unknown origin. Clinical physical examination at the age of 10, he showed clinical features of Joubert syndrome including typical facial dysmorphism, ataxia, severe psychomotor delay, oculomotor apraxia and molar tooth sign on brain MRI. Whole exome sequencing analysis identified a novel compound heterozygous c.725A > G p.Asn242Ser and c.313-3 T > G p.Lys105Valfs*16 TMEM67 variant in the proband and the affected fetus. These two variants were inherited from each parent and confirmed by Sanger sequencing. The variant c.725A > G p.Asn242Ser was previously documented in patients with JS, the novel splice-site c.313-3 T > G p.Lys105Valfs*16 TMEM67 variant produced an aberrant transcript with the loss of four nucleotides of exon 03. CONCLUSION: This study confirms the diagnosis of Joubert syndrome in a Vietnamese family and expands the mutational spectrum of TMEM67 sequence variations. We also highlight the importance of molecular approaches to unravel underlying mechanisms of human genetic disorders. Early precise diagnosis could help provide further accurate genetic counseling for recurrence-risk assessment, future diagnostic option, management as well as treatment guidance for rare disorders.


Subject(s)
Abnormalities, Multiple/genetics , Cerebellum/abnormalities , Eye Abnormalities/genetics , Genetic Predisposition to Disease , Kidney Diseases, Cystic/genetics , Membrane Proteins/genetics , Retina/abnormalities , Abnormalities, Multiple/diagnosis , Abnormalities, Multiple/physiopathology , Adult , Cerebellum/physiopathology , Child , Exons/genetics , Eye Abnormalities/diagnosis , Eye Abnormalities/physiopathology , Female , Humans , Kidney Diseases, Cystic/diagnosis , Kidney Diseases, Cystic/physiopathology , Magnetic Resonance Imaging , Male , Mutation/genetics , Pedigree , Protein Isoforms/genetics , Retina/metabolism , Retina/pathology , Retina/physiopathology , Vietnam , Exome Sequencing
2.
Taiwan J Obstet Gynecol ; 57(3): 435-441, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29880180

ABSTRACT

OBJECTIVE: The thalassemias is a group of hereditary disorders with impaired production of functional hemoglobin. In this report we described a rare case of compound heterozygous mutation of South-East Asia type hereditary persistence of fetal hemoglobin (SEA-HPFH) and ß -thalassemia that allowed prenatal diagnosis to be performed in a subsequent pregnancy in the family. CASE REPORT: The father showed a SEA-HPFH thalassemia trait phenotype, while his genotype revealed that he was heterozygous for the SEA-HPFH deletion; The mother genotype was heterozygote for IVS-II-654 mutation; the second child had co-inherited both parental mutations and was, thus, a compound heterozygote for ß-thalassemia (IVS-II-654)/SEA-HPFH deletion. His phenotype was intermediate ß-thalassemia. Prenatal genotyping of a fetal sample during the third pregnancy confirmed the fetus was only heterozygote for SEA-HPFH deletion and the parents elected to continue the pregnancy. CONCLUSION: We described the clinical and molecular characterization of the first detected case of compound ß-Thalassemia/SEA-HPFH deletion in Northern Vietnam. The report also highlighted the accuracy and necessity of mutation screening for families with thalassemia to inform accurate genetic counseling and targeted prenatal diagnosis when desired.


Subject(s)
Fetal Hemoglobin/genetics , Gene Deletion , Prenatal Diagnosis , beta-Thalassemia/genetics , Child, Preschool , Female , Heterozygote , Humans , Infant, Newborn , Male , Mutation , Pedigree , Polymerase Chain Reaction , Pregnancy , Vietnam , beta-Thalassemia/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...